Table 10.6a

Immunosuppression Use for Induction, 1994 to 2003

Recipients with Intestine Transplants

	Year of Transplant
	1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
Transplants	23	46	45	68	70	73	81	111	107	116
Tx With Immunosuppression Info	23	43	34	66	69	71	79	111	106	116
No Induction Drugs Recorded	82.6%	93.0%	85.3%	92.4%	59.4%	39.4%	30.4%	43.2%	42.5%	25.9%
Drugs	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
ALG
ATG/NRATG/NRATS	0.0%	0.0%	2.9%	3.0%	0.0%	0.0%	1.3%	0.0%	0.9%	1.7%
OKT3	17.4%	7.0%	11.8%	4.5%	2.9%	9.9%	5.1%	7.2%	1.9%	1.7%
Thymoglobulin	0.0%	0.0%	0.0%	0.0%	0.0%	4.2%	0.0%	12.6%	31.1%	45.7%
Zenapax	0.0%	0.0%	0.0%	0.0%	36.2%	49.3%	55.7%	23.4%	10.4%	16.4%
Simulect	0.0%	0.0%	0.0%	0.0%	1.4%	1.4%	12.7%	13.5%	13.2%	1.7%
Campath	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	8.6%

Source: OPTN/SRTR Data as of May 3, 2004.

Induction drugs include any reported antilymphocyte antibodies and antibodies directed against lymphocyte receptors.